V88-25714-32032
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 959 / CA
- Registered
- 2021-10-14
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-04
Dose 1 — Moderna
-
2021-09-02
Dose 2 — Moderna
-
2021-10-14
Registered in v-safe
- 2021-10-14
-
2022-02-11
Dose 3 — Moderna
-
2022-08-14
Survey response — 6 months, dose 3MedDRA: Headache, Pyrexia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Headache, feverMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-04 | Moderna | No |
| 2 | 2021-09-02 | Moderna | No |
| 3 | 2022-02-11 | Moderna | No |
Free text
Release 12 — 6 months, dose 3
Symptoms: Headache, fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release